These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 32343358)

  • 21. Convalescent plasma: A possible treatment protocol for COVID- 19 patients suffering from diabetes or underlying liver diseases.
    Pawar AY; Hiray AP; Sonawane DD; Bhambar RS; Derle DV; Ahire YS
    Diabetes Metab Syndr; 2020; 14(4):665-669. PubMed ID: 32438330
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Editorial: Information on the COVID-19 Pandemic continued.
    Rock G
    Transfus Apher Sci; 2020 Aug; 59(4):102854. PubMed ID: 32660893
    [No Abstract]   [Full Text] [Related]  

  • 23. Convalescent fecal microbiota transplantation as a possible treatment for COVID-19.
    Apartsin K; Smirnova V
    Clin Res Hepatol Gastroenterol; 2020 Oct; 44(5):e113-e114. PubMed ID: 32917563
    [No Abstract]   [Full Text] [Related]  

  • 24. Management of COVID-19 Virus Infection by Convalescent Plasma.
    Cheraghali AM; Abolghasemi H; Eshghi P
    Iran J Allergy Asthma Immunol; 2020 May; 19(S1):3-6. PubMed ID: 32534509
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Convalescent plasma to treat COVID-19.
    Bloch EM
    Blood; 2020 Aug; 136(6):654-655. PubMed ID: 32761219
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reflection on passive immunotherapy in those who need most: some novel strategic arguments for obtaining safer therapeutic plasma or autologous antibodies from recovered COVID-19 infected patients.
    Lanza F; Seghatchian J
    Br J Haematol; 2020 Jul; 190(1):e27-e29. PubMed ID: 32407543
    [No Abstract]   [Full Text] [Related]  

  • 27. Recommendations for caring for patients with severe and nonsevere COVID-19.
    Paladugu S; Donato AA
    Ann Intern Med; 2020 Jul; 173(2):JC3. PubMed ID: 32687760
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recruitment Strategy for Potential COVID-19 Convalescent Plasma Donors.
    Andersen KJ; Klassen SA; Larson KF; Ripoll JG; Senefeld JW; Clayburn AJ; Shepherd JRA; Tseng AS; Wiggins CC; Murphy BM; Ford SK; Johnson CP; Miller AD; Baker SE; Wright RS; Winters JL; Stubbs JR; Joyner MJ; van Buskirk CM
    Mayo Clin Proc; 2020 Nov; 95(11):2343-2349. PubMed ID: 33153626
    [No Abstract]   [Full Text] [Related]  

  • 29. Audio Interview: Capitalizing on Immune Responses to Covid-19.
    Rubin EJ; Baden LR; Morrissey S
    N Engl J Med; 2020 May; 382(21):e93. PubMed ID: 32433859
    [No Abstract]   [Full Text] [Related]  

  • 30. Current studies of convalescent plasma therapy for COVID-19 may underestimate risk of antibody-dependent enhancement.
    Fleming AB; Raabe V
    J Clin Virol; 2020 Jun; 127():104388. PubMed ID: 32361326
    [No Abstract]   [Full Text] [Related]  

  • 31. Passive Immunity for Coronavirus Disease 2019: A Commentary on Therapeutic Aspects Including Convalescent Plasma.
    Lindholm PF; Ramsey G; Kwaan HC
    Semin Thromb Hemost; 2020 Oct; 46(7):796-803. PubMed ID: 32526774
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vaccines, convalescent plasma, and monoclonal antibodies for covid-19.
    Sewell HF; Agius RM; Kendrick D; Stewart M
    BMJ; 2020 Jul; 370():m2722. PubMed ID: 32646867
    [No Abstract]   [Full Text] [Related]  

  • 33. Three patients with X-linked agammaglobulinemia hospitalized for COVID-19 improved with convalescent plasma.
    Jin H; Reed JC; Liu STH; Ho HE; Lopes JP; Ramsey NB; Waqar O; Rahman F; Aberg JA; Bouvier NM; Cunningham-Rundles C;
    J Allergy Clin Immunol Pract; 2020; 8(10):3594-3596.e3. PubMed ID: 32947026
    [No Abstract]   [Full Text] [Related]  

  • 34. Antibody-based immunotherapeutics and use of convalescent plasma to counter COVID-19: advances and prospects.
    Sharun K; Tiwari R; Iqbal Yatoo M; Patel SK; Natesan S; Dhama J; Malik YS; Harapan H; Singh RK; Dhama K
    Expert Opin Biol Ther; 2020 Sep; 20(9):1033-1046. PubMed ID: 32744917
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rapid recovery of a SARS-CoV-2-infected X-linked agammaglobulinemia patient after infusion of COVID-19 convalescent plasma.
    Mira E; Yarce OA; Ortega C; Fernández S; Pascual NM; Gómez C; Alvarez MA; Molina IJ; Lama R; Santamaria M
    J Allergy Clin Immunol Pract; 2020 Sep; 8(8):2793-2795. PubMed ID: 32652231
    [No Abstract]   [Full Text] [Related]  

  • 36. Antibody-based therapies for COVID-19: Can Europe move faster?
    Kazatchkine MD; Goldman M; Vincent JL
    PLoS Med; 2020 May; 17(5):e1003127. PubMed ID: 32369479
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of Convalescent Plasma Therapy in Two COVID-19 Patients with Acute Respiratory Distress Syndrome in Korea.
    Ahn JY; Sohn Y; Lee SH; Cho Y; Hyun JH; Baek YJ; Jeong SJ; Kim JH; Ku NS; Yeom JS; Roh J; Ahn MY; Chin BS; Kim YS; Lee H; Yong D; Kim HO; Kim S; Choi JY
    J Korean Med Sci; 2020 Apr; 35(14):e149. PubMed ID: 32281317
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Convalescent plasma therapy for COVID-19: a tried-and-true old strategy?
    Xi Y
    Signal Transduct Target Ther; 2020 Sep; 5(1):203. PubMed ID: 32934211
    [No Abstract]   [Full Text] [Related]  

  • 39. The therapeutic potential of convalescent plasma therapy on treating critically-ill COVID-19 patients residing in respiratory care units in hospitals in Baghdad, Iraq.
    Rasheed AM; Fatak DF; Hashim HA; Maulood MF; Kabah KK; Almusawi YA; Abdulamir AS
    Infez Med; 2020 Sep; 28(3):357-366. PubMed ID: 32920571
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Convalescent Plasma Therapy in Patients With Severe or Life-Threatening COVID-19: A Metadata Analysis.
    Rabelo-da-Ponte FD; Silvello D; Scherer JN; Ayala AR; Klamt F
    J Infect Dis; 2020 Oct; 222(9):1575-1578. PubMed ID: 32777038
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.